IBRX

ImmunityBio, Inc.

Company with tickers: IBRX

CIK

1326110

CUSIP

45256X103

Shares Outstanding

1,047,353,977

13F Activity (30d)

219 filings 199 filers

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed	Seller	Relationship	Shares	Market Value	Approx. Sale	Broker
2026-06-04	Simon Barry J.	Officer, Director	268,033	$2,946,500	2026-06-04	THE CHARLES SCHWAB CORPORATION
2026-02-23	CHRISTOBEL SELECKY	Director	25,000	$217,500	2026-02-23	Morgan Stanley Smith Barney LLC Executive Financial Services
2026-01-20	Simon Barry J.	Officer, Director	571,967	$5,909,546	2026-01-20	THE CHARLES SCHWAB CORPORATION
2026-01-20	CHRISTOBEL SELECKY	Director	25,000	$138,000	2026-01-20	Morgan Stanley Smith Barney LLC Executive Financial Services
2026-01-16	CHRISTOBEL SELECKY	Director	50,000	$197,500	2026-01-16	Morgan Stanley Smith Barney LLC Executive Financial Services

Showing 1–5 of 5 filings